U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Adrenergic Antagonists [Pharmacological Action]

Tree Number(s): D018674

MeSH Unique ID: D018674

  • profenamine (Supplementary Concept)
  • 1-(2-isopropoxyphenyl)-4-((2-oxopiperidin-1-yl)acetamido)propylpiperazine (Supplementary Concept)
  • Bretylium Tosylate (MeSH Term)
  • Dihydroergocristine (MeSH Term)
  • benoxathian (Supplementary Concept)
  • BE 2254 (Supplementary Concept)
  • (2-(2',6'-dimethoxy)phenoxyethylamino)methylbenzo-1,4-dioxane (Supplementary Concept)
  • ifenprodil (Supplementary Concept)
  • EEDQ (Supplementary Concept)
  • 1-benzylimidazole (Supplementary Concept)
  • BRL 44408 (Supplementary Concept)
  • naftopidil (Supplementary Concept)
  • dapiprazole (Supplementary Concept)
  • nipradilol (Supplementary Concept)
  • medroxalol (Supplementary Concept)
  • 1-(2-pyrimidinyl)piperazine (Supplementary Concept)
  • benalfocin (Supplementary Concept)
  • chlorethylclonidine (Supplementary Concept)
  • BMY 7378 (Supplementary Concept)
  • midaglizole (Supplementary Concept)
  • amosulalol (Supplementary Concept)
  • AR-C239 (Supplementary Concept)
  • SNAP 6201 (Supplementary Concept)
  • 5-carboxamido-1-(N-(3-(4-cyano-4-phenylpiperidin-1-yl)propyl)carboxamido)-6-(2,4-difluorophenyl)-4-ethyl-2-oxo-1,2,3,6-tetrahydropyrimidine (Supplementary Concept)
  • 1-(N-(3-(4-methyl-4-phenylpiperidin-1-yl)propyl)carboxamido)-6-(3,4-difluorophenyl)-5-methoxycarbonyl-4-methoxymethyl-2-oxo-1,2,3,6-tetrahydropyrimidine (Supplementary Concept)
  • 1,2,3,6-tetrahydro-1-(N-((4-(2-nitrophenyl)piperazin-1-yl)propyl)carboxamido)-4-methyl-6-(3,4-difluorophenyl)-2-oxopyrimidine (Supplementary Concept)
  • benextramine (Supplementary Concept)
  • phenylpiperazine (Supplementary Concept)
  • 3-(4-(1-(4-fluorophenyl)-5-(1-methyl-1,2,4-triazol-3-yl)-1H-indol-3-yl)-1-piperidinyl)propionitrile (Supplementary Concept)
  • arotinolol (Supplementary Concept)
  • SK and F 104078 (Supplementary Concept)
  • YM 12617 (Supplementary Concept)
  • 2-(beta-(3-iodo-4-hydroxyphenyl)ethylaminomethyl)tetralone (Supplementary Concept)
  • efaroxan (Supplementary Concept)
  • L 657743 (Supplementary Concept)
  • 5-methylurapidil (Supplementary Concept)
  • 2-methoxyidazoxan (Supplementary Concept)
  • proroxan (Supplementary Concept)
  • 7,8-(methylenedioxy)-14-hydroxyberbane (Supplementary Concept)
  • monatepil (Supplementary Concept)
  • 1-(3-(4-(o-tolyl)piperazin-1-yl)propyl)pyrrolidin-2-one (Supplementary Concept)
  • urapidil (Supplementary Concept)
  • bunazosin (Supplementary Concept)
  • ethyl 4-(3-(4-(2-methoxyphenyl)piperazinyl)propyl)aminoquinazolin-2-carboxylate (Supplementary Concept)
  • JTH 601 (Supplementary Concept)
  • Terazosin (Supplementary Concept)
  • RS 100329 (Supplementary Concept)
  • S 18327 (Supplementary Concept)
  • 4-(2-(2-methoxyphenoxy)ethylaminomethyl)-2,2-diphenyl(1,3)dioxolane (Supplementary Concept)
  • 4-(2-phenoxyethylaminomethyl)-2,2-diphenyl(1,3)dioxolane (Supplementary Concept)
  • 2-(2-(n-4-o-methoxyphenyl-N-1-piperazinyl)ethyl)-1-tetralone (Supplementary Concept)
  • 4-amino-5-(4-fluorophenyl)-6,7-dimethoxy-2-(4-(morpholinocarbonyl)--perhydro-1,4-diazepin-1-yl)quinoline (Supplementary Concept)
  • bucindolol (Supplementary Concept)
  • trimazosin (Supplementary Concept)
  • silodosin (Supplementary Concept)
  • alfuzosin (Supplementary Concept)
  • L 771688 (Supplementary Concept)
  • 6-(1-benzimidazolyl)-2-((4-(2-methoxyphenyl)piperazin-1-yl)butyl)pyridazin-3(2H)-one (Supplementary Concept)
  • 6-(imidazolyl)-2-((4-(2-chlorophenyl)piperazin-1-yl)heptyl)pyridazin-3(2H)-one (Supplementary Concept)
  • 6-(1-indolyl)-2-((4-(2-methoxyphenyl)piperazin-1-yl)butyl)pyridazin-3(2H)-one (Supplementary Concept)
  • 2-(3-(4-(2-isopropoxyphenyl)piperazin-1-yl)propyl)-3a,4,7,7a-tetrahydroisoindole-1,3-dione (Supplementary Concept)
  • N-(2-methyl-(4-indolyl-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexane carboxamide (Supplementary Concept)
  • 2-(3-fluorophenyl)-2,3-dihydro-N-(2-hydroxy-3-(4-(2-(1-methylethoxy)phenyl)-1-piperazinyl)propyl)-1,3-dioxo-1H-isoindole-5-carboxamide (Supplementary Concept)
  • 2-(4-methylphenyll)-2,3-dihydro-N-(2-hydroxy-3-(4-(2-(1-methylethoxy)phenyl)-1-piperazinyl)propyl)-1,3-dioxo-1H-isoindole-5-carboxamide (Supplementary Concept)
  • 8-((4-(2,5-dichlorophenyl)-1-piperazinyl)ethyl)-8-azaspiro(4,5)decane-7,9-dione (Supplementary Concept)
  • 8-(2-(4-(2,5-dichlorophenyl)-1-piperazinyl)ethyl)-8-azaspiro(4,5)dec-9,10-en-7-one (Supplementary Concept)
  • 8-(2-(4-(2,4,5-trifluorophenyl)piperazin-1-yl)ethyl)-8-azaspiro(4.5)decane-7,9-dione (Supplementary Concept)
  • 8-(2-(4-(2,4,5-trifluorophenyl)piperazin-1-yl)-1-methylethyl)-8-azaspiro(4.5)decane-7,9-dione (Supplementary Concept)
  • CP 93393 (Supplementary Concept)
  • 1-((imidazolidin-2-yl)imino)indazole (Supplementary Concept)
  • 1-((imidazolidin-2-yl)imino)-7-methylindazole (Supplementary Concept)
  • cyclazosin (Supplementary Concept)
  • atipamezole (Supplementary Concept)
  • N-(2-(4-(2,3-dihydrobenzo(1,4)dioxin-2-ylmethyl)-(1,4)diazepan-2-yl)ethyl)-2-phenoxynicotinamide (Supplementary Concept)
  • bufuralol (Supplementary Concept)
  • talinolol (Supplementary Concept)
  • indenolol (Supplementary Concept)
  • bopindolol (Supplementary Concept)
  • bufetolol (Supplementary Concept)
  • landiolol (Supplementary Concept)
  • befunolol (Supplementary Concept)
  • tilisolol (Supplementary Concept)
  • butofilolol (Supplementary Concept)
  • 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (Supplementary Concept)
  • epanolol (Supplementary Concept)
  • ICI 89406 (Supplementary Concept)
  • tobanum (Supplementary Concept)
  • CGP 12177 (Supplementary Concept)
  • ICI 118551 (Supplementary Concept)
  • 3-iodopindolol (Supplementary Concept)
  • prizidilol (Supplementary Concept)
  • tertatolol (Supplementary Concept)
  • 5-hydroxypropafenone (Supplementary Concept)
  • bromoacetylalprenololmenthane (Supplementary Concept)
  • cyanopindolol (Supplementary Concept)
  • carazolol (Supplementary Concept)
  • IPS 339 (Supplementary Concept)
  • mepindolol (Supplementary Concept)
  • flestolol (Supplementary Concept)
  • exaprolol (Supplementary Concept)
  • CGP 20712A (Supplementary Concept)
  • bevantolol (Supplementary Concept)
  • esmolol (Supplementary Concept)
  • 4-(2-hydroxy-3-isopropylaminopropoxy)-7-amino-6-iodofluorenone (Supplementary Concept)
  • 3-(2-ethylphenoxy)-1-(1,2,3,4-tetrahydronaphth-1-ylamino)-2-propanol oxalate (Supplementary Concept)
  • L 750355 (Supplementary Concept)
  • 2,3-dihydrothiopyrano(2,3-b)pyridine (Supplementary Concept)
  • Moxisylyte (MeSH Term)
  • Tolazoline (MeSH Term)
  • Dibenzylchlorethamine (MeSH Term)
  • Dihydroergotoxine (MeSH Term)
  • Nicergoline (MeSH Term)
  • Mianserin (MeSH Term)
  • Quinidine (MeSH Term)
  • Ergoloid Mesylates (MeSH Term)
  • Phenoxybenzamine (MeSH Term)
  • Phentolamine (MeSH Term)
  • Piperoxan (MeSH Term)
  • Labetalol (MeSH Term)
  • Prazosin (MeSH Term)
  • Doxazosin (MeSH Term)
  • Carvedilol (MeSH Term)
  • Indoramin (MeSH Term)
  • Tamsulosin (MeSH Term)
  • Lurasidone Hydrochloride (MeSH Term)
  • Idazoxan (MeSH Term)
  • Yohimbine (MeSH Term)
  • Mirtazapine (MeSH Term)
  • Levobunolol (MeSH Term)
  • Bupranolol (MeSH Term)
  • Penbutolol (MeSH Term)
  • Timolol (MeSH Term)
  • Brimonidine Tartrate, Timolol Maleate Drug Combination (MeSH Term)
  • Propranolol (MeSH Term)
  • Dihydroalprenolol (MeSH Term)
  • Nadolol (MeSH Term)
  • Oxprenolol (MeSH Term)
  • Iodocyanopindolol (MeSH Term)
  • Alprenolol (MeSH Term)
  • Carteolol (MeSH Term)
  • Sotalol (MeSH Term)
  • Metipranolol (MeSH Term)
  • Bunolol (MeSH Term)
  • Pindolol (MeSH Term)
  • Betaxolol (MeSH Term)
  • Acebutolol (MeSH Term)
  • Practolol (MeSH Term)
  • Celiprolol (MeSH Term)
  • Bisoprolol (MeSH Term)
  • Atenolol (MeSH Term)
  • Metoprolol (MeSH Term)
  • Butoxamine (MeSH Term)

Supplemental Content

Loading ...